Please Wait

Applying Filters...

Apocard
USDMF
Table View

J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Apocard

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 12 USDMF, 14 CEP/COS, 1 JDMF, 7 EU WC, 1 KDMF, 9 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

127 FDF Dossiers, 31 FDA Orange Book, 66 Europe, 12 Canada, 8 Australia, 6 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 DKSH, 3 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 1 Shanghai Minbiotech, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 4 Kerry, 9 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 18 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 20 Lubricants & Glidants, 17 Disintegrants & Superdisintegrants, 14 Direct Compression, 13 Co-Processed Excipients, 11 Thickeners and Stabilizers, 9 Granulation, 7 Coating Systems & Additives, 6 Chewable & Orodispersible Aids, 5 Film Formers & Plasticizers, 5 Taste Masking, 4 Controlled & Modified Release, 3 Emulsifying Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 53 Regulatory FDF Prices

MARKET PLACE

15 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 5 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/06/2025	Seqens	France	POLYCARBON INDUSTRIES INC DBA PCI SYNTHESIS	15244	FLECAINIDE ACETATE USP	2001-01-15	Inactive	II	N/A
28/06/2025	Unimark Remedies	India	UNIMARK REMEDIES LTD	19272	FLECAINIDE ACETATE USP	2006-03-23	Active	II	N/A

Contact us
to update this info

Apocard

Apocard

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers

12 USDMF

14 CEP/COS

1 JDMF

7 EU WC

1 KDMF

9 NDC API

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

127 FDF Dossiers

31 FDA Orange Book

66 Europe

12 Canada

8 Australia

6 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

5 SPI Pharma

2 DKSH

3 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

1 Shanghai Minbiotech

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

3 DFE Pharma

4 Gangwal Chemicals

1 Ideal Cures

3 Ingredion Pharma Solutions

4 Kerry

9 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

18 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

20 Lubricants & Glidants

17 Disintegrants & Superdisintegrants

14 Direct Compression

13 Co-Processed Excipients

11 Thickeners and Stabilizers

9 Granulation

7 Coating Systems & Additives

6 Chewable & Orodispersible Aids

5 Film Formers & Plasticizers

5 Taste Masking

4 Controlled & Modified Release

3 Emulsifying Agents

2 Rheology Modifiers

1 API Stability Enhancers

1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

53 Regulatory FDF Prices

MARKET PLACE

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons